background
respiratori
viru
rv
panel
emerg
novel
method
detect
influenza
pathogen
known
caus
influenzalik
ill
may
clinic
relev
immunocompromis
patient
purpos
studi
describ
turnaround
time
tat
antimicrobi
stewardship
intervent
associ
inhous
rv
test
compar
sendout
test
immunocompromis
popul
method
irbapprov
pretestposttest
quasiexperi
hospit
detroit
mi
inpati
year
age
solid
organ
bone
marrow
transplant
immunocompromis
condit
intens
care
unit
icu
includ
collect
period
rv
season
octob
march
sendout
test
rv
season
octob
april
inhous
test
tat
measur
specimen
collect
result
time
intervent
tti
measur
specimen
collect
chang
drug
therapi
compar
use
bivari
test
result
one
hundr
thirtyon
patient
includ
patient
clinic
diagnos
pneumonia
microbiolog
confirm
inhous
panel
reduc
tat
tti
posit
test
tabl
common
pathogen
influenza
coronaviru
rhinoviru
differ
observ
group
frequenc
type
intervent
outcom
conclus
diagnost
yield
tti
improv
inhous
rv
test
impact
length
stay
lo
durat
therapi
dot
frequenc
drugrel
intervent
major
intervent
discontinu
oseltamivir
minim
impact
antibacteri
use
disclosur
author
report
disclosur
